Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 672126, 6 pages
http://dx.doi.org/10.1155/2014/672126
Research Article

Antilymphocyte Antibodies in Systemic Lupus Erythematosus: Association with Disease Activity and Lymphopenia

1Department of Rheumatology and Immunology, Peking University People’s Hospital, 11 South Xizhimen Street, Beijing 100044, China
2Department of Rheumatology and Immunology, Peking University Shenzhen Hospital, 1120 Futianlianhua Road, Shenzhen 518036, China

Received 11 December 2013; Revised 30 March 2014; Accepted 31 March 2014; Published 17 April 2014

Academic Editor: Pier-Luigi Meroni

Copyright © 2014 Chun Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis and rheumatism, vol. 40, no. 9, p. 1725, 1997. View at Google Scholar · View at Scopus
  2. W. L. Ng, C. M. Chu, A. K. L. Wu, V. C. C. Cheng, and K. Y. Yuen, “Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus,” QJM, vol. 99, no. 1, pp. 37–47, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. L. M. Vilá, G. S. Alarcón, G. McGwin Jr., H. M. Bastian, B. J. Fessler, and J. D. Reveille, “Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual,” Arthritis Care and Research, vol. 55, no. 5, pp. 799–806, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. H.-H. Yu, L.-C. Wang, J.-H. Lee, C.-C. Lee, Y.-H. Yang, and B.-L. Chiang, “Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients,” Rheumatology, vol. 46, no. 9, pp. 1492–1494, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. Y.-L. Huang, H.-T. Chung, C.-J. Chang, K.-W. Yeh, L.-C. Chen, and J.-L. Huang, “Lymphopenia is a risk factor in the progression of carotid intima-media thickness in juvenile-onset systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 60, no. 12, pp. 3766–3775, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. R. P. Messner, M. S. Kennedy, and J. G. Jelinek, “Antilymphocyte antibodies in systemic lupus erythematosus. Effect on lymphocyte surface characteristics,” Arthritis and Rheumatism, vol. 18, no. 3, pp. 201–206, 1975. View at Google Scholar · View at Scopus
  7. K. K. Mittal, R. D. Rossen, J. T. Sharp, M. D. Lidsky, and W. T. Butler, “Lymphocyte cytotoxic antibodies in systemic lupus erythematosus,” Nature, vol. 225, no. 5239, pp. 1255–1256, 1970. View at Publisher · View at Google Scholar · View at Scopus
  8. R. B. Lies, R. P. Messner, and R. C. Williams Jr., “Relative T cell specificity of lymphocytotoxins from patients with systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 16, no. 3, pp. 369–375, 1973. View at Google Scholar · View at Scopus
  9. J. B. Winfield, R. J. Winchester, P. Wernet, S. M. Fu, and H. G. Kunkel, “Nature of cold reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 18, no. 1, pp. 1–8, 1975. View at Google Scholar · View at Scopus
  10. V. Agnello, D. Koffler, J. W. Eisenberg, R. J. Winchester, and H. G. Kundel, “C1g precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types,” Journal of Experimental Medicine, vol. 134, no. 3, pp. 228–241, 1971. View at Google Scholar · View at Scopus
  11. C. Bombardier, D. D. Gladman, M. B. Urowitz, D. Caron, and C. H. C. Chi Hsing Chang, “Derivation of the SLEDAI: a disease activity index for lupus patients. The Committee on Prognosis Studies in SLE,” Arthritis and Rheumatism, vol. 35, no. 6, pp. 630–640, 1992. View at Publisher · View at Google Scholar · View at Scopus
  12. M. B. Magalhães, L. M. Da Silva, J. C. Voltarelli, E. A. Donadi, and P. Louzada Jr., “Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations,” Scandinavian Journal of Rheumatology, vol. 36, no. 6, pp. 442–447, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. S. D. Denburg, S. A. Behmann, R. M. Carbotte, and J. A. Denburg, “Lymphocyte antigens in neuropsychiatric systemic lupus erythematosus: relationship of lymphocyte antibody specificities to clinical disease,” Arthritis and Rheumatism, vol. 37, no. 3, pp. 369–375, 1994. View at Google Scholar · View at Scopus
  14. J. B. Winfield and T. Mimura, “Pathogenetic significance of anti-lymphocyte autoantibodies in systemic lupus erythematosus,” Clinical Immunology and Immunopathology, vol. 63, no. 1, pp. 13–16, 1992. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Osman and A. J. G. Swaak, “Lymphocytotoxic antibodies in SLE: a review of the literature,” Clinical Rheumatology, vol. 13, no. 1, pp. 21–27, 1994. View at Google Scholar · View at Scopus
  16. J. Revillard, C. Vincent, and S. Rivera, “Anti-β2 microglobulin lymphocytotoxic autoantibodies in systemic lupus erythematosus,” Journal of Immunology, vol. 122, no. 2, pp. 614–618, 1979. View at Google Scholar · View at Scopus
  17. Y. Shoenfeld, R. Zamir, H. Joshua, G. Lavie, and J. Pinkhas, “Human monoclonal anti-DNA antibodies react as lymphocytotoxic antibodies,” European Journal of Immunology, vol. 15, no. 10, pp. 1024–1028, 1985. View at Google Scholar · View at Scopus
  18. Y. Amasaki, S. Kobayashi, T. Takeda et al., “Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia,” Clinical and Experimental Immunology, vol. 99, no. 2, pp. 245–250, 1995. View at Google Scholar · View at Scopus
  19. I. García-Valladares, Y. Atisha-Fregoso, Y. Richaud-Patin et al., “Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia,” Lupus, vol. 15, no. 9, pp. 600–605, 2006. View at Publisher · View at Google Scholar · View at Scopus